Registered Nurse · Founder & Editor
Ian Gauntt, RN, BSN
Ian Gauntt, RN, BSN, is the founder and editor of Peptide News Network, a Biosignal Media publication. A registered nurse with nearly a decade of critical care experience, he writes and edits the site's coverage of peptide research, clinical trials, and regulation, working from primary sources — peer-reviewed papers, trial registries, and FDA documents. His clinical background informs how the reporting reads the evidence, but Peptide News Network is a news and education publication, not a provider of individualized medical advice.
Reach the newsroom at hello@peptidenewsnetwork.com, or follow new stories through the RSS feed. More about who publishes this site is on the About page.
Recent stories
- Interpretable ML Framework for Peptide Lead Optimization
- SELECT Analysis: Semaglutide and Liver Risk Markers
- Biotech Synthesis of BPC‑157 in Bacillus licheniformis
- Scorpion venom peptides: what the research shows
- N-PEP-12 Supplementation: Attention Trial Results
- LL‑37 Levels Reflect Sleep Quality in Obstructive Sleep Apnea
- GLP-1 Receptor Agonists: What 2025 Research Shows
- Systematic ranking of peptide drugs in new review
- Semaglutide Policy: What New Data Show
- First‑in‑class non‑GLP‑1 peptide advances metabolic therapy
- Vosoritide Trial: A Phase 3 Study in Kids
- FDA’s Revised Draft Guidance Reshapes Generic Peptide Path